Revlimid® (lenalidomide)

Overview | Product information | Accredo services | Contact team

Revlimid is indicated for the treatment of patients who have myelodysplastic syndrome (MDS). Patients with MDS have bone marrow that does not produce enough mature blood cells. This causes a lack of healthy blood cells that can function properly in the body. Revlimid helps promote immune responses to prevent inflammation and treats anemia. 1

Revlimid in combination with dexamethasone is indicated for the treatment of multiple myeloma patients who have received at least one prior therapy. 1

Accredo is a member of the RevAssist ® program and is qualified to dispense Revlimid. Because of potential toxicity, Revlimid is only available to select prescribers and pharmacists who are registered and who have completed the required training for the RevAssist program.

For more information, please visit Revlimid.com.